Additive toxicity arising from combined use of immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with renal or endometrial carcinoma: Protocol for a rapid systematic review
- Resource Type
- Source
- In
MethodsX June 2024 12 - Subject
- Language
- ISSN
- 2215-0161